Dr James Price
Senior Lecturer and Honorary Consultant in Infection, Brighton & Sussex Medical School, Brighton
Dr James Price graduated in Medicine from St. George’s Hospital Medical School, London, in 2005. James was awarded a Walport NIHR Academic Clinical Fellowship during which he completed his PhD focusing on whole-genome sequencing to inform nosocomial S. aureus infection. In 2014 James was appointed as a NIHR Clinical Lecturer where he continued to develop his research in prevention of healthcare-associated infection and antimicrobial resistance. In 2019, James took up a position as Infection Consultant at Imperial College Healthcare NHS Trust and progressed to Director of Infection Prevention and Control. Alongside this he worked as Honorary Senior Lecturer at the NIHR Health Protection Research Unit in Healthcare-associated Infection and Antimicrobial Resistance at Imperial College London. In 2022, James took up the position of Senior Lecturer at Brighton and Sussex Medical School and Honorary Consultant in Infection at University Hospitals Sussex NHS Foundation Trust where he pursues his interests in (i) translational application of data and novel technologies to inform on infection prevention and antimicrobial resistance and (ii) sustainable approaches to infection prevention and control to support decarbonising healthcare. To date, his publications have received over 5000 citations, and he has won the prestigious Barnett Christie Prize Lecture, the Royal College of Pathologists Research Medal in Microbiology, the ESCMID Young Investigators award, the Healthcare Infection Society Early Career Award and a National Clinical Impact Award (N3). James is Council Member (2016-) of the Healthcare Infection Society and chairs the Professional Development Committee. In addition to being a fellow of the Royal College of Pathologists and the Royal College of Physicians, James is an active member of the National Quality Assurance Advisory Panel for microbiology, the NHS England and Improvement IPC oversight group, and has sat on the Scientific Advisory Group for Emergencies (SAGE) hospital-onset COVID infection subgroup.